These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12388797)

  • 1. Vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics.
    Griffin JL; Muller D; Woograsingh R; Jowatt V; Hindmarsh A; Nicholson JK; Martin JE
    Physiol Genomics; 2002 Dec; 11(3):195-203. PubMed ID: 12388797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charting the effects of antioxidant therapy in the diseased brain: focus on "vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics".
    Järvelä I; Glueck SB
    Physiol Genomics; 2002 Dec; 11(3):183-4. PubMed ID: 12464692
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolomic investigation of CLN6 neuronal ceroid lipofuscinosis in affected South Hampshire sheep.
    Pears MR; Salek RM; Palmer DN; Kay GW; Mortishire-Smith RJ; Griffin JL
    J Neurosci Res; 2007 Nov; 85(15):3494-504. PubMed ID: 17510975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in neuropathology of the neuronal ceroid lipofuscinoses.
    Goebel HH; Schochet SS; Jaynes M; Brück W; Kohlschütter A; Hentati F
    Mol Genet Metab; 1999 Apr; 66(4):367-72. PubMed ID: 10191130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral assessment in mouse models of neuronal ceroid lipofuscinosis using a light-cued T-maze.
    Wendt KD; Lei B; Schachtman TR; Tullis GE; Ibe ME; Katz ML
    Behav Brain Res; 2005 Jun; 161(2):175-82. PubMed ID: 15885820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspective of biochemical research in the neuronal ceroid-lipofuscinosis.
    Rider JA; Dawson G; Siakotos AN
    Am J Med Genet; 1992 Feb; 42(4):519-24. PubMed ID: 1609832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease.
    Pears MR; Cooper JD; Mitchison HM; Mortishire-Smith RJ; Pearce DA; Griffin JL
    J Biol Chem; 2005 Dec; 280(52):42508-14. PubMed ID: 16239221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis.
    Herrmann P; Druckrey-Fiskaaen C; Kouznetsova E; Heinitz K; Bigl M; Cotman SL; Schliebs R
    J Neurosci Res; 2008 Jun; 86(8):1857-70. PubMed ID: 18265413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered protein patterns in brains of children with neuronal ceroid lipofuscinosis.
    Wisniewski KE; Gordon-Majszak W; Maslinski S; Heaney-Kieras J
    Am J Med Genet; 1992 Feb; 42(4):568-74. PubMed ID: 1376969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic studies on adult neuronal-ceroid lipofuscinosis (NCL).
    Goebel HH; Braak H; Seidel D; Doshi R; Marsden CD; Gullotta F
    Clin Neuropathol; 1982; 1(4):151-62. PubMed ID: 7168921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis.
    Siintola E; Partanen S; Strömme P; Haapanen A; Haltia M; Maehlen J; Lehesjoki AE; Tyynelä J
    Brain; 2006 Jun; 129(Pt 6):1438-45. PubMed ID: 16670177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A metabolomic comparison of mouse models of the Neuronal Ceroid Lipofuscinoses.
    Salek RM; Pears MR; Cooper JD; Mitchison HM; Pearce DA; Mortishire-Smith RJ; Griffin JL
    J Biomol NMR; 2011 Apr; 49(3-4):175-84. PubMed ID: 21461951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct neuropathologic phenotypes after disrupting the chloride transport proteins ClC-6 or ClC-7/Ostm1.
    Pressey SN; O'Donnell KJ; Stauber T; Fuhrmann JC; Tyynelä J; Jentsch TJ; Cooper JD
    J Neuropathol Exp Neurol; 2010 Dec; 69(12):1228-46. PubMed ID: 21107136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.
    Pontikis CC; Cella CV; Parihar N; Lim MJ; Chakrabarti S; Mitchison HM; Mobley WC; Rezaie P; Pearce DA; Cooper JD
    Brain Res; 2004 Oct; 1023(2):231-42. PubMed ID: 15374749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging.
    Kopra O; Vesa J; von Schantz C; Manninen T; Minye H; Fabritius AL; Rapola J; van Diggelen OP; Saarela J; Jalanko A; Peltonen L
    Hum Mol Genet; 2004 Dec; 13(23):2893-906. PubMed ID: 15459177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies.
    Topçu M; Tan H; Yalnizoğlu D; Usubütün A; Saatçi I; Aynaci M; Anlar B; Topaloğlu H; Turanli G; Köse G; Aysun S
    Turk J Pediatr; 2004; 46(1):1-10. PubMed ID: 15074367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and metabolic changes in the cortex of mice lacking the functional presynaptic active zone protein bassoon: a combined 1H-NMR spectroscopy and histochemical study.
    Angenstein F; Hilfert L; Zuschratter W; Altrock WD; Niessen HG; Gundelfinger ED
    Cereb Cortex; 2008 Apr; 18(4):890-7. PubMed ID: 17652465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of early postnatal retinal pathology in a mouse model of neuronal ceroid lipofuscinosis.
    Seigel GM; Wagner J; Wronska A; Campbell L; Ju W; Zhong N
    Eye (Lond); 2005 Dec; 19(12):1306-12. PubMed ID: 15565184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuronal ceroid lipofuscinosis Cln8 gene expression is developmentally regulated in mouse brain and up-regulated in the hippocampal kindling model of epilepsy.
    Lonka L; Aalto A; Kopra O; Kuronen M; Kokaia Z; Saarma M; Lehesjoki AE
    BMC Neurosci; 2005 Apr; 6():27. PubMed ID: 15826318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-utero and post-delivery supplementation of motor neuron degeneration mutant mice with polyunsaturated fatty acids does not alter the clinical or pathological course.
    Bennett MJ; Boriack RL; Birch DG
    Neuropediatrics; 1997 Feb; 28(1):82-4. PubMed ID: 9151333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.